X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/synaptogenix-and-cleveland-clinic-to-submit-investigational-new-drug-ind-application-to-fda-for-clinical-trial-of-bryostatin-1-in-multiple-sclerosis-301880709.html
https://www.prnewswire.com/news-releases/new-peer-reviewed-article-demonstrates-extended-therapeutic-potential-of-synaptogenixs-bryostatin-for-alzheimers-disease-301517850.html
https://www.pharmacompass.com/pdf/news/synaptogenix-moves-forward-with-clinical-development-plans-for-bryostatin-1-1646391047.pdf
https://www.amriglobal.com/blog/news-and-events/news/bryologyx-announces-agreements-with-neurotrope-to-acquire-bryostatin-1-immuno-oncology-data-package-supply-synthetic-bryostatin-1-synthesized-by-amri/
https://www.reuters.com/article/us-neurotrope-study/neurotrope-shares-crash-after-alzheimers-drug-fails-in-trial-idUSKCN1VU1HD
https://www.prnewswire.com/news-releases/neurotrope-completes-enrollment-of-confirmatory-phase-2-study-of-bryostatin-1-in-moderate-to-severe-alzheimers-disease-300811313.html
https://www.prnewswire.com/news-releases/neurotrope-announces-cooperative-research-and-development-agreement-for-bryostatin-1-with-the-national-cancer-institute-300786942.html
https://www.contractpharma.com/contents/view_breaking-news/2019-02-04/neurotrope-nci-enter-development-agreement/
https://www.prnewswire.com/news-releases/neurotrope-enters-into-collaboration-with-the-nemours--alfred-i-dupont-hospital-for-children-to-initiate-a-clinical-trial-in-fragile-x-syndrome-300706794.html
http://www.neurotropebioscience.com/Welcome_to_Neurotrope_BioScience/NeurotropeReceives.html
Market Place
Share 
